Angioedema
📧 Sign up to get email alerts when something new happens for Angioedema.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria [Phase 2]
Phase 2 clinical trial update reporting efficacy and safety data for povorcitinib in adults with chronic spontaneous urticaria; results comp…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: COrticosteroids in acUte uRticAria in emerGency dEpartment [Phase 3]
This Phase 3 trial evaluating corticosteroids for acute urticaria in the emergency department has completed. The snippet does not report fin…
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: A Study to Review the Treatment and Outcomes of Teenagers and Adults With Non-histaminergic Angioedema With Normal C1 Inhibitor in Canada
This clinical trial update describes a completed study in Canada evaluating treatment approaches and outcomes for teenagers and adults with …
-
CLINICAL_TRIALS trial_result · 2024-06-17Clinical Trial Update: A Study of Long-Term Safety and Efficacy of Lanadelumab for Prevention of Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor [Phase 3]
A Phase 3 long-term safety and efficacy study of lanadelumab for prevention of acute attacks in non-histaminergic angioedema with normal C1-…
-
CLINICAL_TRIALS trial_result · 2024-04-16Clinical Trial Update: Mepolizumab in Episodic Angioedema With Eosinophilia [Phase 2]
Phase 2 trial exploring mepolizumab for episodic angioedema with eosinophilia; study terminated with results posted in 2024.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) [Phase 3]
Phase 3 trial update for Lanadelumab in teenagers and adults with non-histaminergic angioedema with normal C1-inhibitor has completed, with …
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: Dupilumab in Chronic Spontaneous Urticaria [Phase 2]
Phase 2 clinical trial update for dupilumab in chronic spontaneous urticaria and recurrent angioedema completed.
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: Impact of Omalizumab on Quality of Life Measures and Angioedema Occurrence in Patients With CSU Refractory to Therapy [Phase 3]
Phase 3 trial assessing omalizumab's impact on quality of life and angioedema frequency in patients with chronic spontaneous urticaria refra…
-
CLINICAL_TRIALS trial_result · 2019-07-01Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis [Phase 2]
Phase 2 randomized trial evaluating omalizumab versus placebo for idiopathic anaphylaxis completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Study of Clinical, Biological Characteristics and Quality of Life of Patients With Hereditary or Acquired Non Drug-induced Bradykinin-mediated Angioedema, Monitored in Besançon's Partner Site Reference Center for Studies of Kinin-mediated Angioedema (CREAK)
Completed clinical study conducted at Besançon assessing clinical and biological characteristics and quality of life in patients with heredi…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Analysis of the Availability of the Treatments for ACE-I and ARB-induced Angioedema
The update analyzes the availability of treatments for ACE inhibitor- and ARB-induced angioedema, summarizing current access to therapies.
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Bradykinin Receptor Blocker in ACE Inhibitor-associated Angioedema [Phase 1]
Phase 1 trial of a Bradykinin receptor blocker for ACE inhibitor-associated angioedema was terminated.
-
CLINICAL_TRIALS trial_result · 2012-08-31Clinical Trial Update: Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema [Phase 2, Phase 3]
Complete Phase 2 and Phase 3 trial updates for recombinant human C1 esterase inhibitor in treating acute attacks of hereditary angioedema, w…
-
CLINICAL_TRIALS trial_result · 2012-02-16Clinical Trial Update: The Efficacy of a Pseudoallergen-Free Diet in the Treatment of Chronic Idiopathic Urticaria and/or Angioedema [NA]
This entry reports an update on a clinical trial evaluating whether a pseudoallergen-free diet can treat chronic idiopathic urticaria and/or…
-
CLINICAL_TRIALS trial_result · 2011-12-23Clinical Trial Update: AMelioration of Angiotensin Converting Enzyme Inhibitor Induced Angioedema Study [Phase 2]
Phase 2 clinical trial evaluating a treatment for ACE inhibitor-induced angioedema. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2009-05-04Clinical Trial Update: Kinetics, Efficacy and Safety of C1-Esteraseremmer-N [Phase 2]
Phase 2 trial results for C1-Esteraseremmer-N assess kinetics, efficacy, and safety in hereditary angioedema. The study is reported as compl…
-
CLINICAL_TRIALS trial_result · 2009-01-29Clinical Trial Update: Significance of an Elimination and Provocation Diet in Patients With Chronic Urticaria [NA]
A completed trial examined the significance of an elimination and provocation diet in patients with chronic urticaria (and angioedema).